Liu, D., Huang, Y., Chen, B., Zeng, J., Guo, N., Zhang, S., . . . Li, W. (2011). Activation of mammalian target of rapamycin pathway confers adverse outcome in nonsmall cell lung carcinoma. Cancer, 117(16), 3763-3773. https://doi.org/10.1002/cncr.25959
Chicago-Zitierstil (17. Ausg.)Liu, Dan, et al. "Activation of Mammalian Target of Rapamycin Pathway Confers Adverse Outcome in Nonsmall Cell Lung Carcinoma." Cancer 117, no. 16 (2011): 3763-3773. https://doi.org/10.1002/cncr.25959.
MLA-Zitierstil (9. Ausg.)Liu, Dan, et al. "Activation of Mammalian Target of Rapamycin Pathway Confers Adverse Outcome in Nonsmall Cell Lung Carcinoma." Cancer, vol. 117, no. 16, 2011, pp. 3763-3773, https://doi.org/10.1002/cncr.25959.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.